1-anilino-8-naphthalenesulfonate has been researched along with Short Bowel Syndrome in 3 studies
1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.
Short Bowel Syndrome: A malabsorption syndrome resulting from extensive operative resection of the SMALL INTESTINE, the absorptive region of the GASTROINTESTINAL TRACT.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Navab, F | 1 |
O'Keefe, SJ | 1 |
Haymond, MW | 1 |
Bennet, WM | 1 |
Oswald, B | 1 |
Nelson, DK | 1 |
Shorter, RG | 1 |
Hardt, PD | 1 |
Helfrich, C | 1 |
Klauke, T | 1 |
Klör, HU | 1 |
3 other studies available for 1-anilino-8-naphthalenesulfonate and Short Bowel Syndrome
Article | Year |
---|---|
Management of short-bowel syndrome.
Topics: Adaptation, Physiological; Anti-Bacterial Agents; Crohn Disease; Diet; Fluid Therapy; Humans; Intest | 1984 |
Long-acting somatostatin analogue therapy and protein metabolism in patients with jejunostomies.
Topics: Adult; Aged; Amino Acids; Amylases; Delayed-Action Preparations; Female; Gastric Acid; Gastrointesti | 1994 |
Liquid pancreatic enzyme therapy for a patient with short bowel syndrome and chronic pancreatitis in a complicated case of Crohn's disease.
Topics: Chronic Disease; Crohn Disease; Enteral Nutrition; Female; Humans; Immunosuppressive Agents; Lipase; | 1999 |